Andrew Snelling, FRCS(Plast.)

Consultant Plastic & Reconstructive Surgeon
Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
Norwich, England, United Kingdom

Presentation(s):

• 59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials

  Friday, March 24, 2023
  10:44 AM – 10:54 AM

  Disclosure information not submitted.

• 62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma

  Friday, March 24, 2023
  11:14 AM – 11:24 AM

  Disclosure information not submitted.